These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Regional citrate anticoagulation in CVVH: a new protocol combining citrate solution with a phosphate-containing replacement fluid. Morabito S; Pistolesi V; Tritapepe L; Zeppilli L; Polistena F; Fiaccadori E; Pierucci A Hemodial Int; 2013 Apr; 17(2):313-20. PubMed ID: 22882732 [TBL] [Abstract][Full Text] [Related]
6. Slow Continuous Ultrafiltration in Regional Citrate Anticoagulation Performed with a Standard Fluid Infusion Central Venous Catheter in Intensive Care Unit for Fluid Overload in Acute on Chronic Heart Failure: A Case Report. Nalesso F; Stefanelli F; Cattarin L; Billo M; Gnappi M; Partesano G; Cacciapuoti M; Babuin L; Calò LA J Clin Med; 2023 Jan; 12(3):. PubMed ID: 36769636 [TBL] [Abstract][Full Text] [Related]
7. Safety of regional citrate anticoagulation for continuous sustained low efficiency dialysis (C-SLED) in critically ill patients. Finkel KW; Foringer JR Ren Fail; 2005; 27(5):541-5. PubMed ID: 16152991 [TBL] [Abstract][Full Text] [Related]
8. Improving the delivery of continuous renal replacement therapy using regional citrate anticoagulation. Swartz R; Pasko D; O'Toole J; Starmann B Clin Nephrol; 2004 Feb; 61(2):134-43. PubMed ID: 14989634 [TBL] [Abstract][Full Text] [Related]
9. Continuous venovenous hemofiltration with citrate-based replacement fluid: efficacy, safety, and impact on nutrition. Bihorac A; Ross EA Am J Kidney Dis; 2005 Nov; 46(5):908-18. PubMed ID: 16253732 [TBL] [Abstract][Full Text] [Related]
10. Regional citrate anticoagulation using a citrate-based substitution solution for continuous venovenous hemofiltration in cardiac surgery patients. Thoenen M; Schmid ER; Binswanger U; Schuepbach R; Aerne D; Schmidlin D Wien Klin Wochenschr; 2002 Feb; 114(3):108-14. PubMed ID: 12060967 [TBL] [Abstract][Full Text] [Related]
11. Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk. Kalb R; Kram R; Morgera S; Slowinski T; Kindgen-Milles D Ther Apher Dial; 2013 Apr; 17(2):202-12. PubMed ID: 23551677 [TBL] [Abstract][Full Text] [Related]
12. Continuous veno-venous hemofiltration using a phosphate-containing replacement fluid in the setting of regional citrate anticoagulation. Morabito S; Pistolesi V; Tritapepe L; Vitaliano E; Zeppilli L; Polistena F; Fiaccadori E; Pierucci A Int J Artif Organs; 2013 Dec; 36(12):845-52. PubMed ID: 24362894 [TBL] [Abstract][Full Text] [Related]
18. Citrate anticoagulation during CVVH in high risk bleeding patients. Cubattoli L; Teruzzi M; Cormio M; Lampati L; Pesenti A Int J Artif Organs; 2007 Mar; 30(3):244-52. PubMed ID: 17417764 [TBL] [Abstract][Full Text] [Related]
19. Low-dose citrate continuous veno-venous hemofiltration (CVVH) and acid-base balance. Naka T; Egi M; Bellomo R; Cole L; French C; Wan L; Fealy N; Baldwin I Int J Artif Organs; 2005 Mar; 28(3):222-8. PubMed ID: 15818544 [TBL] [Abstract][Full Text] [Related]
20. Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding. Palsson R; Niles JL Kidney Int; 1999 May; 55(5):1991-7. PubMed ID: 10231464 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]